Whether for delivering anesthesia or nutrients, the Intravenous (IV) Solution Manufacturing industry provides hospitals with an array of IV solutions. Since the industry relies mainly on downstream demand from hospitals, the number of people with health insurance plays a critical role in determining demand for IV solutions. Forthcoming changes to the nation's healthcare system under the Patient Protection and Affordable Care Act of 2010 are anticipated to increase the number of insured Americans over the next five years. In turn, hospital demand is projected to rise and help support demand for IV solutions.
Companies in this industry primarily engage in manufacturing substances that may be infused directly into a vein using a venous access device. Intravenous (IV) solutions may be used to correct electrolyte imbalances, to deliver medications, for blood transfusion or as fluid replacement. Solutions specifically for animals are excluded from this industry.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.